Adimmune Revenue

Adimmune had revenue of 888.24M TWD in the quarter ending September 30, 2024, a decrease of -8.74%. This brings the company's revenue in the last twelve months to 1.57B, down -13.19% year-over-year. In the year 2023, Adimmune had annual revenue of 1.79B, down -20.72%.

Revenue (ttm)

1.57B

Revenue Growth

-13.19%

P/S Ratio

5.97

Revenue / Employee

2.79M

Employees

564

Market Cap

9.38B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.79B	-466.53M	-20.72%
Dec 31, 2022	2.25B	457.85M	25.52%
Dec 31, 2021	1.79B	-75.37M	-4.03%
Dec 31, 2020	1.87B	569.46M	43.81%
Dec 31, 2019	1.30B	477.32M	58.04%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	8.32B
Caliway Biopharmaceuticals	49.98M
Bora Pharmaceuticals Co., LTD.	16.71B
Lotus Pharmaceutical	17.59B
Lumosa Therapeutics	37.82M
Oneness Biotech	112.20M
Polaris Group	75.65M
Center Laboratories	1.57B

Revenue Rankings